1.Massad, E et al. (2017) On the origin and timing of Zika virus introduction in Brazil. Epidemiology & Infection 145, 2303–2312.
3.Wilder-Smith, A et al. (2017) ZikaPLAN: Zika preparedness Latin American network. Global Health Action 10, 1398485.
4.Summers, DJ, Acosta, RW and Acosta, AM. (2015) Zika virus in an American recreational traveller. Journal of Travel Medicine 22, 338–340.
5.Quam, MB and Wilder-Smith, A. (2016) Estimated global exportations of Zika virus infections via travellers from Brazil from 2014 to 2015. Journal of Travel Medicine 23, pii: taw059.
6.Shinohara, K et al. (2016) Zika fever imported from Thailand to Japan, and diagnosed by PCR in the urines. Journal of Travel Medicine 23.
7.Sokal, A et al. (2016) Zika virus infection: report of the first imported cases in a Paris travel centre. Journal of Travel Medicine 24.
8.Wang, G et al. (2018) A cluster of Zika virus infection among travellers returning to China from Samoa: a case tracing study. Journal of Travel Medicine 25.
9.Wilder-Smith, A, Chang, CR and Leong, WY (2018) Zika in travellers 1947–2017: a systematic review. Journal of Travel Medicine 25.
10.Pan American Health Organization (PAHO)/World Health Organization (WHO) (2016). Zika Epidemiological Update, 15 December 2016. PAHO/WHO.
11.Pabbaraju, K et al. (2016) Simultaneous detection of Zika, chikungunya and dengue viruses by a Multiplex real-time RT-PCR assay. Clinical Virology 83, 66–71.
12.Massad, E et al. (2016) Estimated Zika virus importations to Europe by travellers from Brazil. Global Health Action 9, 31669.
13.Rocklov, J et al. (2016) Assessing seasonal risks for the introduction and mosquito-borne spread of Zika virus in Europe. EBio Medicine 9, 250–256.
14.Wilder-Smith, A et al. (2018) Zika vaccines and therapeutics: landscape analysis and challenges ahead. BMC Medicine 16, 84.
16.Tebas, P et al. (2017) Safety and immunogenicity of an anti-Zika virus DNA vaccine – preliminary report. New England Journal of Medicine online 4 October 2017. doi: 10.1056/NEJMoa1708120.
18.O'Reilly, KM et al. (2018) Projecting the end of the Zika virus epidemic in Latin America: a modelling analysis. BMC Medicine 16, 180.
21.Massad, E et al. (2017) Estimating the size of Aedes aegypti populations from dengue incidence data: implications for the risk of yellow fever outbreaks. Infectious Diseases Modeling 2, 441–454.
22.Massad, E et al. (2018) The risk of urban yellow fever resurgence in Aedes-infested American cities. Epidemiology & Infection 146, 1219–1225.
23.Chernick, MR (2008) Bootstrap Methods: A Guide for Practitioners and Researchers. New Jersey: John Wiley & Sons.
24.Blower, S and Dowlatabadi, H (1994) Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. International Statistical Review/Revue Internationale De Statistique 62, 229–243.
25.Villela, DAM et al. (2017) Zika in Rio de Janeiro: assessment of basic reproduction number and comparison with dengue outbreaks. Epidemiology & Infection Page 1 of 9. doi: 10.1017/S0950268817000358.
26.Martins Netto, E et al. (2017) High Zika virus seroprevalence in salvador, Northeastern Brazil limits the potential for further outbreaks. MBio 8, e01390–17.
27.Massad, E et al. (2018b) Estimating the probability of dengue virus introduction and secondary autochthonous cases in Europe. Nature Scientific Reports 8, 4629.
28.Gubler, DJ (1989) Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig Lecture. American Journal of Tropical Medicine and Hyiene 40, 571–578.
29.Amaku, M et al. (2014) A comparative analysis of the relative efficacy of vector-control strategies against dengue fever. Bulletin of Mathematical Biolology 76, 697–717.
30.Coelho, GE et al. (2008) Dynamics of the 2006/2007 dengue outbreak in Brazil. Memórias do Instituto Oswaldo Cruz 103, 535–539.
31.Paixao, ES et al. (2018) Asymptomatic prenatal Zika virus infection and congenital Zika syndrome. Open Forum of Infectious Diseases 5, ofy073.